Recursos de colección

Repositório do Hospital Prof. Doutor Fernando Fonseca (3.582 recursos)

The Hospital Prof. Dr. Fernando Fonseca E.P.E. (HFF) institutional repository collects, preserves and disseminates the intellectual output of its professionals in digital format. Its aims are to increase the HFF’s investigation visibility and citation impact, to foster scientific communication and to preserve the HFF’s intellectual memory.


Mostrando recursos 1 - 20 de 86

  1. Crises convulsivas: quando a causa é vascular

    Lima, A

  2. In response to: “understanding elevated P v−a CO 2 gap and  P v−a CO 2 /C a−v O 2 ratio in venous hyperoxia condition”

    Saludes, P; Proença, L; Gruartmoner, G; Enseñat, L; Pérez-Madrigal, A; Espinal, C; Mesquida, J

  3. Leishmaniose: um caso raro de pancitopénia

    Silva, MI; Corte-Real, AM

  4. Large Hiatal Hernia

    Sousa, C; Duarte, J

  5. Crioglobulinemia: a ponta do iceberg

    Silva, R

  6. Extended Release-Niacin increases anti-ApoA-I antibodies that block the anti-oxidant effect of HDL-C: the EXPLORE clinical trial.

    Batuca, JR; Amaral, M; Favas, C; Paula, F; AMES, PR; Papoila, AL; Alves, J
    Extended Release-Niacin (ERN) is the most effective agent for increasing high-density lipoprotein-cholesterol (HDL-C). Having previously identified anti-HDL antibodies, we investigated whether ERN affected the antioxidant capacity of HDL and whether ERN was associated with the production of antibodies against HDL (aHDL) and apolipoprotein A-I (aApoA-I). METHODS: Twenty-one patients older than 18 years, with HDL-C ≤ 40 mg/dL (men) or ≤ 50 mg/dL (women) were randomly assigned to receive daily ERN (n = 10) or placebo (n = 11) for two sequential 12-week periods, with 4 weeks of wash-out before cross-over. Primary outcome was change of paraoxonase-1 (PON1) activity and secondary outcomes were changes in aHDL and aApoA-I antibodies. Clinical Trial Unique Identifier: EudraCT 2006-006889-42. RESULTS: The...

  7. Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study.

    Amengual, O; Forastiero R, R; Sugiura-Ogasawara, M; Otomo, K; Oku, K; Favas, C; Alves, J; Žigon, P; Ambrožič, A; Tomšič, M; Ruiz-Arruza, I; Ruiz-Irastorza, G; Bertolaccini, ML; Norman, GL; Shums, Z; Arai, J; Murashima, A; Tebo, AE; Gerosa, M; Meroni, PL; Rodriguez-Pintó, I; Cervera, R; Swadzba, J; Musial, J; Atsumi, T
    OBJECTIVE: A task force of scientists at the International Congress on Antiphospholipid Antibodies recognized that phosphatidylserine-dependent antiprothrombin antibodies (aPS/PT) might contribute to a better identification of antiphospholipid syndrome (APS). Accordingly, initial and replication retrospective, cross-sectional multicentre studies were conducted to ascertain the value of aPS/PT for APS diagnosis. METHODS: In the initial study (eight centres, seven countries), clinical/laboratory data were retrospectively collected. Serum/plasma samples were tested for IgG aPS/PT at Inova Diagnostics (Inova) using two ELISA kits. A replication study (five centres, five countries) was carried out afterwards. RESULTS: In the initial study (n = 247), a moderate agreement between the IgG aPS/PT Inova and MBL ELISA...

  8. Nutrição artificial em utentes em fim de vida

    Afonso, T

  9. O Papel do Enfermeiro na Equipa Intra-Hospitalar de Suporte em Cuidados Paliativos

    Afonso, T

  10. Central venous-to-arterial carbon dioxide difference and the effect of venous hyperoxia: A limiting factor, or an additional marker of severity in shock?

    Saludes, P; Proença, L; Gruartmoner, G; Enseñat, L; Pérez-Madrigal, A; Espinal, C; Mesquida, J
    Central venous-to-arterial carbon dioxide difference (PcvaCO2) has demonstrated its prognostic value in critically ill patients suffering from shock, and current expert recommendations advocate for further resuscitation interventions when PcvaCO2 is elevated. PcvaCO2 combination with arterial-venous oxygen content difference (PcvaCO2/CavO2) seems to enhance its performance when assessing anaerobic metabolism. However, the fact that PCO2 values might be altered by changes in blood O2 content (the Haldane effect), has been presented as a limitation of PCO2-derived variables. The present study aimed at exploring the impact of hyperoxia on PcvaCO2 and PcvaCO2/CavO2 during the early phase of shock. Prospective interventional study. Ventilated patients...

  11. Readmissões hospitalares como marcador de qualidade: análise das readmissões a 30 dias numa enfermaria de medicina interna

    Melo, L; Caetano, J; Oliveira, S

  12. Refractory Wegener's granulomatosis presenting with alveolar haemorrhage, treated with rituximab

    Caetano, J; Neves, M; Oliveira, S; Alves, J

  13. Xanthogranulomatous pyelonephritis presenting as palmoplantar keratoderma.

    Caetano, J; Neves, M; Oliveira, S; Alves, J

  14. Treatment of systemic sclerosis with tocilizumab.

    Neves, M; Oliveira, S; Amaral, M; Alves, J

  15. Lessons from London: the BMJ editorial process.

    Pestana, P; Ramalho, A; Revés, J

  16. Tumor fantasma do pulmão

    Vasconcelos, P; Bragança, N

  17. Fenómeno de Raynaud

    Seidi, M; Henriques, C

  18. Otorragia: nem sempre uma otite média aguda

    Duarte, J; Sousa, C; Henriques, C

  19. Missão em África: a minha experiência

    Guedes, Q

  20. A propósito dos 20 anos do Hospital Prof. Doutor Fernando Fonseca: o Serviço de Medicina 2

    Dutschmann, L

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.